Texas A&M Softball

Kennedy discusses the jump from SEC softball to the AUSL

Former Texas A&M pitcher Emiley "Lefty" Kennedy joined Wednesday's edition of TexAgs Live from Japan to talk about her time in the AUSL. Kennedy also broke down Trisha Ford & Co.'s regular-season campaign as the Aggies face Auburn in the 2026 SEC Tournament.
By David Nuño
May 6, 2026
5.8k Views
Discuss
Story Poster
Photo by Will Huffman, TexAgs
Free Preview
Watch the full version by becoming a Premium subscriber.
Try Premium for $1
No Thanks
Trial available for new subscribers only.

Key notes from Emiley Kennedy interview

  • My team in Japan is very accommodating. Ally Carda and I have a translator. She’s always with us and talks to the coaches. Not very many of the coaches speak English. Thankfully, a lot of the players do know quite a few words softball-wise. I also have a tutor, so I’m learning Japanese myself. That’s been challenging, but the communication part is doable.
     
  • Going to Japan was something I talked to my GM at the Bandits about.
To view this content, you must be a TexAgs Premium subscriber.
Try Premium for $1
See Subscription Benefits →
Trial only available to users who have never subscribed or participated in a previous trial
Discuss
Tags
Trisha Ford TexAgs Live Kay Naegeli TexAgs Live Feature AUSL Emiley Kennedy Sidne Peters Sydney Lessentine Grace Sparks Softball Texas A&M Oklahoma
Show All
Auburn 2026
More Softball
See All →
Veteran RHP Sidne Peters is part of A&M's new-look pitching staff
By Kaylee Dreyer
Right-hander Darby Burnett is among Aggie softball's eight freshmen
By Kay Naegeli
Texas A&M welcomes 2026 class into the Athletics Hall of Fame
By TexAgs
Softball Receives 2027 SEC Opponents, Dates
By Kayla Gaither
Discussion from...

Kennedy discusses the jump from SEC softball to the AUSL

4,738 Views | 0 Replies | Last: 4 mo ago by David Nuño
There are not any replies to this post yet.
Refresh
Page 1 of 1
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.